Search Results - "Stephen Kegg"
-
1
Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy
Published in AIDS (London) (15-05-2014)“…The objective of this study is to estimate life expectancies of HIV-positive patients conditional on response to antiretroviral therapy (ART). Patients aged…”
Get full text
Journal Article -
2
Hepatitis B, hepatitis C and mortality among HIV-positive individuals
Published in AIDS (London) (28-11-2017)“…OBJECTIVES:To compare rates of all-cause, liver-related and AIDS-related mortality among individuals who are HIV mono-infected with those co-infected with HIV…”
Get full text
Journal Article -
3
Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo-Controlled Study
Published in The Journal of infectious diseases (15-04-2015)“…Background. Human immunodeficiency virus (HIV)-infected individuals are at increased risk of herpes zoster (HZ), even in the antiretroviral therapy (ART) era…”
Get full text
Journal Article -
4
Who gets single tablet regimens (STR), and why?
Published in Journal of the International AIDS Society (01-11-2014)“…Introduction The BHIVA guidelines now feature three single tablet regimens (STRs) as recommended treatments for HIV‐positive people new to therapy [1]. They…”
Get full text
Journal Article -
5
HIV outcomes during the COVID‐19 pandemic in people of Black ethnicities living with HIV in England
Published in HIV medicine (01-07-2024)“…Objectives To describe HIV care outcomes in people of Black ethnicities living in England during the severe acute respiratory syndrome coronavirus 2…”
Get full text
Journal Article -
6
Cardiovascular disease risk in people of African ancestry with HIV in the United Kingdom
Published in HIV medicine (29-08-2024)“…Our objective was to describe the prevalence of cardiovascular disease (CVD) risk factors in people of African ancestry with HIV in the UK. We conducted a…”
Get full text
Journal Article -
7
Clinical characteristics and outcomes of HIV-associated immune complex kidney disease
Published in Nephrology, dialysis, transplantation (01-12-2016)“…The pathogenesis and natural history of HIV-associated immune complex kidney disease (HIVICK) is not well understood. Key questions remain unanswered,…”
Get full text
Journal Article -
8
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial
Published in The lancet HIV (01-05-2018)“…Doravirine is a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) with a pharmacokinetic profile supporting once-daily dosing, and potent in-vitro…”
Get full text
Journal Article -
9
Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial
Published in The lancet HIV (01-07-2021)“…In DISCOVER, a multinational, randomised controlled trial, emtricitabine and tenofovir alafenamide compared with emtricitabine and tenofovir disoproxil…”
Get full text
Journal Article -
10
Incomplete Reversibility of Estimated Glomerular Filtration Rate Decline Following Tenofovir Disoproxil Fumarate Exposure
Published in The Journal of infectious diseases (01-08-2014)“…Background. Tenofovir disoproxil fumarate (TDF) has been linked to renal impairment, but the extent to which this impairment is reversible is unclear. We aimed…”
Get full text
Journal Article -
11
Clinical epidemiology of COVID‐19 in people of black ethnicity living with HIV in the UK
Published in HIV medicine (01-05-2024)“…Objectives To describe the clinical epidemiology of COVID‐19 in people of black ethnicity living with HIV in the UK. Methods We investigated the incidence and…”
Get full text
Journal Article -
12
Chronic Kidney Disease Risk in African and Caribbean Populations With HIV
Published in The Journal of infectious diseases (20-10-2018)“…We conducted an observational cohort study of end-stage kidney disease (ESKD) in >7000 African and Caribbean people with HIV in the UK. Using Poisson…”
Get full text
Journal Article -
13
Bone mineral density, kidney function and participant‐reported outcome measures in women who switch from tenofovir disoproxil emtricitabine and a nonnucleoside reverse transcriptase inhibitor to abacavir, lamivudine and dolutegravir
Published in HIV medicine (01-04-2022)“…Objectives Tenofovir disoproxil fumarate (TDF) is associated with reduced bone mineral density (BMD). The aim of the study was to evaluate changes in BMD in…”
Get full text
Journal Article -
14
A continuum of HIV care describing mortality and loss to follow-up: a longitudinal cohort study
Published in The lancet HIV (01-06-2018)“…The cross-sectional HIV care continuum is widely used to assess the success of HIV care programmes among populations of people with HIV and the potential for…”
Get full text
Journal Article -
15
Switching to dolutegravir plus rilpivirine versus maintaining current antiretroviral therapy regimen in virologically suppressed people with HIV-1 and the Lys103Asn (K103N) mutation: 48-week results from a randomised, open-label pilot clinical trial
Published in The lancet HIV (01-03-2024)“…The combination of dolutegravir plus rilpivirine has been studied in people with virologically suppressed HIV with no previous history of treatment failure or…”
Get full text
Journal Article -
16
HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK
Published in Journal of antimicrobial chemotherapy (01-12-2016)“…Darunavir is considered to have a high genetic barrier to resistance. Most darunavir-associated drug resistance mutations (DRMs) have been identified through…”
Get full text
Journal Article -
17
Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance
Published in Journal of antimicrobial chemotherapy (01-03-2019)“…Abstract Objectives In subjects with transmitted thymidine analogue mutations (TAMs), boosted PIs (PI/b) are often chosen to overcome possible resistance to…”
Get full text
Journal Article -
18
The contribution of viral genotype to plasma viral set-point in HIV infection
Published in PLoS pathogens (01-05-2014)“…Disease progression in HIV-infected individuals varies greatly, and while the environmental and host factors influencing this variation have been widely…”
Get full text
Journal Article -
19
An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs
Published in Journal of antimicrobial chemotherapy (01-07-2017)“…HIV-1 subtype C might have a greater propensity to develop K65R mutations in patients with virological failure compared with other subtypes. However, the…”
Get full text
Journal Article -
20
Predicting virological decay in patients starting combination antiretroviral therapy
Published in AIDS (London) (17-07-2016)“…OBJECTIVE:Model trajectories of viral load measurements from time of starting combination antiretroviral therapy (cART), and use the model to predict whether…”
Get full text
Journal Article